Eric Lindquist
Directeur Général chez InnoSIGN BV
Profil
Eric Lindquist's current job is as the Chief Executive Officer at InnoSIGN BV.
Formerly, he worked as the Director of Business Development & Alliances at Roche Diagnostics Corp., Director of Sales & Marketing at ApoCell, Inc., Principal at Abbott Laboratories and Johnson & Johnson, Global VP of Customer & Companion Diagnostic at Asuragen, Inc., Global Vice President of Oncology & Rare Disease at Natera, Inc., and Chief Business Officer at Celcuity, Inc. from 2019 to 2022.
He completed his undergraduate degree at the University of Minnesota and holds an MBA from Capella University LLC.
Postes actifs de Eric Lindquist
| Sociétés | Poste | Début |
|---|---|---|
InnoSIGN BV
 InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | Directeur Général | 26/03/2024 |
Anciens postes connus de Eric Lindquist
| Sociétés | Poste | Fin |
|---|---|---|
| CELCUITY INC. | Corporate Officer/Principal | 01/09/2022 |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
| NATERA, INC. | Corporate Officer/Principal | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Formation de Eric Lindquist
| Capella University LLC | Masters Business Admin |
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| CELCUITY INC. | Health Technology |
| NATERA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
ApoCell, Inc.
 ApoCell, Inc. Medical/Nursing ServicesHealth Services ApoCell, Inc. engages in molecular biomarker detection. It offers platform technologies, assay development, circulating tumor cells, genomics, flow cytometry, FISH and immunohistochemistry, immunofluorescence image analysis and cytokine Profiling services. The company was founded by Darren W. Davis in 2004 and is headquartered in Houston, TX. | Health Services |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
InnoSIGN BV
InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | Commercial Services |
